Systemic chemotherapy in metastatic TNBC polarizes effector T cell differentiation
Collectively, this study is the first to provide potential diagnostic and therapeutic targets of East Asian chemotherapy-treated mTNBC with regard to effector T cells.
Authors
- Hyundong Yoon
- Hye-Yeon Ju (ORCID: https://orcid.org/0000-0002-3208-4611)
- Tae Kon Kim (ORCID: https://orcid.org/0000-0002-5182-3870)
- Seung Pil Jung (ORCID: https://orcid.org/0000-0003-3967-2974)
- Serk In Park (ORCID: https://orcid.org/0000-0001-8643-5096)
- Mi-Ryung Han
Institutions
- Incheon National University (KR)
- Vanderbilt University (US)
- Korea University Medical Center (KR)
- Korea University (JP)
- Vanderbilt-Ingram Cancer Center
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1186/s12935-025-04011-6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vanderbilt University
- Vanderbilt-Ingram Cancer Center
- National Research Foundation
- Korea University
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea